To compare a new and easy way ( CET score) with the traditional way(RegiSCAR) in patients of drug allergy.
Not Applicable
- Conditions
- Health Condition 1: L270- Generalized skin eruption due to drugs and medicaments taken internally
- Registration Number
- CTRI/2021/11/038121
- Lead Sponsor
- Sukhdeep Singh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patients giving consent, All maculopapular drug rash patients
Exclusion Criteria
Patients in sepsis, admitted in ICU for other acute illnesses ,SCAR other than DRESS including erythema multiforme, steven johnson syndrome, toxic epidermal necrolysis, drug induced vasculitis and acute generalized exanthematous pustulosis. Patients not giving consent.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To validate CET score in patients of DRESS Syndrome Vs RegiSCAR as gold standard by assessing sensitivity,specificity and predictive valueTimepoint: 1.5 years
- Secondary Outcome Measures
Name Time Method (a)To find lead time advantage in diagnosis of DRESS using CET score Vs RegiSCAR. <br/ ><br>(b)To assess the cost-benefit in terms of cost of tests, costs of in patient admission, loss of work and commute between two scores. <br/ ><br>Timepoint: 1.5 years